Bev Shea – OMERACT

$ 4.50

4.6
(312)
In stock
Description

Myositis – OMERACT

OMERACT consensus-based operational definition of contextual factors in rheumatology clinical trials: A mixed methods study - ScienceDirect

A Draft Modified Core Domain Set for Patient-Reported Outcomes (PRO) in Patients with Idiopathic Inflammatory Myopathies (IIM): An Omeract Report - ACR Meeting Abstracts

Safety – OMERACT

Safety – OMERACT

JCM, Free Full-Text

Towards consensus in defining and handling contextual factors within rheumatology trials: An initial qualitative study from an OMERACT working group

About us

Myositis – OMERACT

IFH Associate Faculty - Rutgers